This increased vulnerability may rely on the higher dependency on splicing of cancer cells with increased transcriptional activity, such as MYC-driven tumors [57] and tumors displaying addiction to oncogenic transcription factors, such as the AR in prostate cancer [90,91]. This evidence concerns the gene MYC and Familial prostate cancer.